Iowa Representative proposes bipartisan bill to enhance healthcare cost transparency and access through Association Health Plans and PBM regulation, amidst debates over ACA subsidy extensions.
House Republicans unveil a health care proposal focusing on employer plans and PBM regulation but excluding an extension of ACA subsidies expiring end of 2025, amid congressional gridlock.
House Republicans introduce healthcare reforms including PBM transparency and cost-sharing reforms amid the expiration of enhanced ObamaCare subsidies potentially affecting 22 million Americans.
House Republicans propose a 111-page healthcare reform plan focusing on lowering premiums, codifying association health plans, and enhancing transparency for pharmacy benefit managers amid ACA subsidy extension debates.
House Republicans unveil a healthcare plan as ACA premium tax credits face expiration, potentially raising costs for 22 million Americans. The proposal emphasizes employer-sponsored plans and pharmacy benefit manager reforms but excludes subsidy extensions. Bipartisan efforts seek temporary relief amid political impasse.
Medicaid cuts and the expiration of ACA subsidies under the OBBBA are causing premium increases and coverage challenges in the U.S. health insurance market, with legislative and regulatory efforts underway.
U.S. Senate to vote on extending Obamacare subsidies as Republicans propose alternative healthcare legislation targeting premium tax credits and drug pricing transparency. Key impacts on insurance premiums and healthcare cost regulation.
Explore key 2025 updates on healthcare affordability debates in Congress, CMS 2027 Medicare policy proposals, PBM reform legislation, and HHS AI strategy shaping U.S. insurance and Medicare landscapes.
North Carolina employers are shifting toward transparent pharmacy benefit managers to address rising drug costs and compliance risks. Learn how alternative PBMs impact insurance affordability and market dynamics.
The AMA report reveals high market concentration among pharmacy benefit managers (PBMs), vertical integration with insurers, and calls for increased transparency and regulatory reforms to control drug prices and enhance competition.